REQUEST A DEMO
Total
USD $0.00
Search more companies

Lux Pharm Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling | Educational Services | Ambulatory Health Care Services
Full name: Lux Pharm Sp. z o.o. Profile Updated: March 18, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Lux Pharm Sp. z o.o. is a company based in Poland, with its head office in Gdansk. The enterprise operates in the Department Stores industry. It was established on December 03, 2015. The latest financial highlights indicate a net sales revenue increase of 23.32% in 2025. Its’ total assets recorded a growth of 71.15%. The net profit margin of Lux Pharm Sp. z o.o. increased by 0.85% in 2025.

Headquarters
Ul. Piotrkowska 25
Gdansk; Pomorskie; Postal Code: 80-001

Contact Details: Purchase the Lux Pharm Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Lux Pharm Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Lux Pharm Sp. z o.o. report to view the information.
Incorporation Date:
December 03, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
74%
Purchase this report to view the information.
26%
Company Performance
Financial values in the chart are available after Lux Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
23.32%
Total Operating Revenue
23.32%
Operating Profit
37.94%
EBITDA
36.84%
Net Profit/Loss for the Period
55.9%
Total Assets
71.15%
Total Equity
43.05%
Operating Profit Margin
0.58%
Net Profit Margin
0.85%
Return on Equity (ROE)
1.36%
Debt / Equity
-4.64%
Quick Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?